Found 62 matching trials
A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer PHASE2 A Single Arm Phase II Trial of BMN 673 for Inoperable, Advanced Endometrial...
Show More Location
Royal Sussex County Hospital
Learn More & Join Trial
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide PHASE2 The purpose of this study is to find out whether talazoparib in combination...
Show More Learn More & Join Trial
Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction PHASE1 This phase I trial studies the side effects and best dose of talazoparib in...
Show More Location
Multiple Locations
Learn More & Join Trial
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer PHASE2 This purpose of this study is to test if talazoparib is safe and evaluate i...
Show More Location
Stanford University
Learn More & Join Trial
PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors PHASE1 This phase I trial studies the side effects and the best dose of poly (aden...
Show More Location
Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC PHASE3 The purpose of the study is to evaluate the safety and efficacy of talazopa...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
BMN 673 (Talazoparib), an Oral PARP Inhibitor, in People With Deleterious BRCA1/2 Mutation-Associated Ovarian Cancer Who Have Had Prior PARP Inhibitor Treatment PHASE2 Background:
\- The new drug BMN 673 (talazoparib) has been shown to fight ...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors PHASE1 Avelumab in combination with talazoparib will be investigated in patients w...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
Testing the Addition of the Anti-Cancer Drug Talazoparib to the Combination of Carboplatin and Paclitaxel for the Treatment of Advanced Cancer PHASE1 This phase I trial studies the side effects and best dose of talazoparib wh...
Show More Location
Rutgers Cancer Institute of New Jersey
Learn More & Join Trial
Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers PHASE1 This is a randomized, 2-period, 2-sequence crossover study to evaluate the ...
Show More Location
Covance Clinical Research Unit Inc.
Learn More & Join Trial